Business · 22/06/2011Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance for Low Glucose Suspend Device Systems
Summary
The FDA has released a draft guidance document outlining recommendations to improve the safety and effectiveness of low glucose suspend device systems, which are intended for investigational use and premarket approval.
Original source language: Federal Register — Health and Human ServicesOpen original release →